Kazuhiro Tateda - Infectious Diseases

Author Information

Kazuhiro Tateda is a prominent researcher affiliated with the Department of Microbiology and Infectious Diseases at Toho University School of Medicine in Tokyo, Japan. He also holds positions in the Department of Infection Control at Toho University Medical Center, Omori Hospital, and the Laboratory Microbiological Section at the same institution. His work is primarily focused on the field of infectious diseases, showcasing a strong commitment to advancing medical science through research and innovation.

Research Contributions

Kazuhiro Tateda has made significant contributions to the field of infectious diseases, with a particular focus on antimicrobial resistance, viral infections like COVID-19 and influenza, and diagnostic methodologies. His recent work includes evaluating risk factors associated with uric acid elevation in COVID-19 patients treated with favipiravir, and investigating the clinical manifestations of hospitalized influenza patients. Tateda is also involved in research on microbial community structures, diagnostic test challenges for SARS-CoV-2, and the genetic environment of antibiotic-resistant pathogens. His studies are essential in understanding and addressing the complexities of infectious diseases, contributing to improved patient outcomes and public health strategies.

Aliases

Kazuhiro Tateda is also known by other aliases including K. Tateda and K Tateda. These variations are commonly found in academic publications and databases.

Publication and Citation Metrics

Metric	Value
Publication Count	461
Citation Count	8994
H-index	48

Publications:

Evaluation of risk factors for uric acid elevation in COVID-19 patients treated with favipiravir

DOI: 10.1016/j.diagmicrobio.2022.115640

Year: 2022

Clinical manifestations of hospitalized influenza patients without risk factors: A prospective multicenter cohort study in Japan via internet surveillance.

DOI: 10.1016/j.jiac.2022.02.001

Year: 2022

Impact of Helicobacter pylori infection on fluid duodenal microbial community structure and microbial metabolic pathways

DOI: 10.1186/s12866-022-02437-w

Year: 2022

Study on the usefulness of Direct Saliva sample Collection (DiSC) by polyester swab

DOI: 10.1101/2022.02.25.22271529

Year: 2022

Choice of SARS-CoV-2 diagnostic test: challenges and key considerations for the future

DOI: 10.1080/10408363.2022.2045250

Year: 2022

Change in antimicrobial susceptibility of pathogens isolated from surgical site infections over the past decade in Japanese nation-wide surveillance study.

DOI: 10.1016/j.jiac.2021.03.010

Year: 2021

Effect of the Photocatalyst under Visible Light Irradiation in SARS-CoV-2 Stability on an Abiotic Surface.

DOI: 10.4265/bio.26.119

Year: 2021

P5‐73: Clinical characteristics of pulmonary melioidosis diagnosed at respiratory Department of the Tertiary Hospital in Southern Vietnam

DOI: 10.1111/resp.14150_280

Year: 2021

Genetic Environment Surrounding blaOXA-55-like in Clinical Isolates of Shewanella algae Clade and Enhanced Expression of blaOXA-55-like in a Carbapenem-Resistant Isolate

DOI: 10.1128/mSphere.00593-21

Year: 2021

P5‐72: Lipid involvements on inflammatory changes and clinical outcomes in patients with COVID‐19

DOI: 10.1111/resp.14150_279

Year: 2021

How can personal hygiene prevent infectious diseases?

What Does the Future Hold?

What are the Challenges in Infectious Disease Education?

What are the Phases of the Inflammatory Response?

How are Sporozoites Transmitted?

What is the Role of Artificial Intelligence in Infectious Diseases?

What are the Advantages of HTS in Infectious Disease Research?

What are the Symptoms of ARDS?

How Do Aedes Mosquitoes Transmit Diseases?

Why is Fatty Acid Biosynthesis a Therapeutic Target?

Partnered Content Networks

Relevant Topics